Marc Funk
Director/Board Member bij RECIPHARM AB (PUBL)
Profiel
Marc Funk was the founder of GeneProt, Inc., a company founded in 2000, where he served as the General Counsel from 2000 to 2004.
Currently, Mr. Funk holds the position of Director at Recipharm AB, Chime Biologics Ltd., and Bionter AG.
In his former roles, he was the Chief Executive Officer at Lonza Group AG from 2009 to 2019 and the General Counsel at Merck Serono SA from 2004 to 2008.
Mr. Funk obtained a graduate degree from the University of Geneva and The Fletcher School.
Actieve functies van Marc Funk
Bedrijven | Functie | Begin |
---|---|---|
RECIPHARM AB (PUBL) | Director/Board Member | 01-01-2024 |
Chime Biologics Ltd.
Chime Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016. | Director/Board Member | - |
Bionter AG
Bionter AG Wholesale DistributorsDistribution Services Bionter AG is a start-up that specializes in providing particle counters for the pharmaceutical and biotechnology industries. The company is based in Riehen, Switzerland, and Tobias Werk has been the CEO since 2020. The Swiss company is dedicated to revolutionizing the industry with innovative breakthrough developments that increase quality, safety, and cost-effectiveness. | Director/Board Member | - |
Eerdere bekende functies van Marc Funk
Bedrijven | Functie | Einde |
---|---|---|
LONZA GROUP AG | Chief Executive Officer | 12-11-2019 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | General Counsel | 01-01-2008 |
GeneProt, Inc. | Chief Executive Officer | 01-01-2004 |
Opleiding van Marc Funk
University of Geneva | Graduate Degree |
The Fletcher School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LONZA GROUP AG | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Recipharm AB
Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Health Technology |
GeneProt, Inc. | |
Chime Biologics Ltd.
Chime Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016. | Commercial Services |
Bionter AG
Bionter AG Wholesale DistributorsDistribution Services Bionter AG is a start-up that specializes in providing particle counters for the pharmaceutical and biotechnology industries. The company is based in Riehen, Switzerland, and Tobias Werk has been the CEO since 2020. The Swiss company is dedicated to revolutionizing the industry with innovative breakthrough developments that increase quality, safety, and cost-effectiveness. | Distribution Services |